APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.05
+4.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -20.16x
- Price / sales
- 7.56x
- Price / cash flow
- -3.57x
Enterprise value
- Enterprise value
- $61.6M
- EV / sales
- 7.25x
- EV / EBITDA
- -6.58x
- EV / EBIT
- -6.51x
- Market cap
- $64.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025